6745

Repurposing Approved Drugs for New Indications

Tabach Yuval, HUJI, School of Medicine - IMRIC, Developmental Biology and Cancer Research

 

Repurposing Approved Drugs for New Indications

TTM: 6-2019-6745

Prof. Yuval Tabach

Category

Life Sciences and Biotechnology   

Keywords

Drug Repurposing, Computational biology, Personalized

medicine

 

Our innovation
The genetic revolution which has taken place in recent years brings new opportunities to the field of drug discovery and repositioning. Using advanced comparative genomic and data integration, our lab has been developing a state-of-the-art AI algorithm which maps drug and food supplements that are useful in treating diseases and improving health conditions. To create this algorithm, we have been integrating and analyzing massive amounts of genomic data from 1,600 genomes, 14,000 compounds, 20,000 human genes, and a comprehensive database of phenotypic data.

Opportunity
We now propose harnessing our unique approach to discover drugs that fight against various pathogens and disease states. We have already demonstrated that applying our unique AI algorithm has yielded a preliminary list of possible drugs with the promise of affecting various medical conditions.

 

Contact for more information:

Ariela Markel
VP, Business Development, Healthcare
+972-2-6586608
Contact ME: